- Home
- FNLC vs SGMO Comparison
FNLC vs SGMO Comparison
Compare FNLC & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNLC
- SGMO
- Stock Information
- Founded
- FNLC 1864
- SGMO 1995
- Country
- FNLC United States
- SGMO United States
- Employees
- FNLC N/A
- SGMO N/A
- Industry
- FNLC Major Banks
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FNLC Finance
- SGMO Health Care
- Exchange
- FNLC Nasdaq
- SGMO Nasdaq
- Market Cap
- FNLC 284.1M
- SGMO 242.0M
- IPO Year
- FNLC 1999
- SGMO 2000
- Fundamental
- Price
- FNLC $24.51
- SGMO $0.92
- Analyst Decision
- FNLC
- SGMO Buy
- Analyst Count
- FNLC 0
- SGMO 6
- Target Price
- FNLC N/A
- SGMO $5.17
- AVG Volume (30 Days)
- FNLC 19.8K
- SGMO 3.9M
- Earning Date
- FNLC 04-16-2025
- SGMO 05-08-2025
- Dividend Yield
- FNLC 5.85%
- SGMO N/A
- EPS Growth
- FNLC N/A
- SGMO N/A
- EPS
- FNLC 2.43
- SGMO N/A
- Revenue
- FNLC $79,740,000.00
- SGMO $52,291,000.00
- Revenue This Year
- FNLC N/A
- SGMO N/A
- Revenue Next Year
- FNLC N/A
- SGMO N/A
- P/E Ratio
- FNLC $10.23
- SGMO N/A
- Revenue Growth
- FNLC 0.35
- SGMO N/A
- 52 Week Low
- FNLC $21.77
- SGMO $0.30
- 52 Week High
- FNLC $31.05
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- FNLC 36.81
- SGMO 39.24
- Support Level
- FNLC $24.34
- SGMO $0.94
- Resistance Level
- FNLC $26.38
- SGMO $1.05
- Average True Range (ATR)
- FNLC 0.55
- SGMO 0.11
- MACD
- FNLC -0.11
- SGMO 0.01
- Stochastic Oscillator
- FNLC 8.33
- SGMO 44.21
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.